 The drug being tested in this study is called vedolizumab. Vedolizumab is being tested to treat people who have ulcerative colitis UC or Crohns disease CD. This study will look at the PK, safety and tolerability of vedolizumab following a single IV infusion of vedolizumab IV in healthy adult Chinese participants. 